Histamine causes adjacent endothelial cells to retract from each another. We examined phosphorylation of the 20-kD myosin light chain (MLC20) in human umbilical vein endothelial cells (HUVECs) exposed to histamine to determine if we could find evidence to support the hypothesis that retraction of these cells in response to histamine represents an actomyosininitiated contraction of the endothelial cytoskeleton. We found that MLC20 in HUVECs was constitutively phosphorylated 
Introduction
Edema caused by molecules such as histamine is associated with the separation of adjacent endothelial cells from one another (1) (2) (3) (4) (5) (6) (7) (8) . Although there are multiple reports documenting this phenomenon, the mechanism of cell separation remains incompletely understood.
Agents that disrupt actin filaments or that chelate calcium and breakdown calcium-dependent cell-cell and cell-substrate adhesion cause edema and separation of adjacent endothelial cells (6, 7, 9 ). These data demonstrate that separation may account for cell retraction when tethering forces are released.
Others have suggested that the separation ofadjacent endothelial cells from each other involves initiation of an active contraction mediated by actin and myosin (10, 11) . Support for this hypothesis comes from two observations. First, Wysolmerski and Lagunoff( 12) found that retraction of endothelial cells exposed to histamine was prevented if the cells were depleted of ATP before exposure to histamine. Second, 100 gM calcium, ATP, myosin light chain kinase (MLCK), I and calmodulin caused phosphorylation of the 20-kD myosin light chain (MLC20) and contraction ofthe cytoskeleton ofendothelial cells after their cell membranes were removed with detergents(l0, 11, 13) .
Endothelial cell retraction in response to histamine is well documented (4) . When histamine binds to an HI receptor on an endothelial cell it initiates a signal transduction cascade that results in an increase in cell calcium and diacylglycerol (DAG) (2) . The increase in cell calcium and DAG could stimulate an acute increase in MLC20 phosphorylation by MLCK (calcium dependent) or by protein kinase C (PKC) (calcium and DAG dependent). The acute increase in light chain phosphorylation could then increase actomyosin contraction and centripetal tension (14) (15) (16) ).
In the experiments described in this manuscript we investigated the effects of histamine on phosphorylation of MLC20 in human umbilical vein endothelial cells (HUVECs). We were interested to determine if MLC20 was constitutively phosphorylated, if histamine acutely increased MLC20 phosphorylation in HUVECs, and, if so, how much phosphorylation of MLC20 increased. Because MLC20 phosphorylation is mediated by both MLCK and PKC in other nonmuscle cells, we also constructed tryptic peptide maps of the phosphorylated MLC20 to directly determine which kinase was responsible for MLC20 phosphorylation in HUVECs, constitutively and after stimulation with histamine ( 15) . We previously found that increasing cell cAMP prevented HUVECs from retracting in response to histamine, but the increase in cAMP did not prevent the increase in cell calcium (2) . In other cells, one of the effects of increased cell cAMP is to inhibit MLC20 phosphorylation by MLCK ( 17 ). Hence, we were also interested in determining if increased cell cAMP prevents increased MLC20 phosphorylation in histamine-stimulated HUVECs. If it does, it would, in part, explain how cAMP prevents the response of HUVECs to histamine. Purification of human platelet myosin MLC20. Human platelet MLC20 was purified from whole platelet myosin using the procedure described by Daniel and Adelstein ( 18) . Preparations were used ifcontaminating kinases were not present. Whole-platelet myosin was purified according to Sellers et al. (19 Labeled cells were exposed to either buffer, histamine (I0 1-mol/ liter), or a mixture of agents used to increase cell cAMP (8-bromocAMP, l0-4 mol/liter, forskolin, 2 X Il0-mol/liter, and theophylline, l0-3 mol/liter) with or without histamine. There was no difference in MLC20 phosphorylation between cells exposed to the mixture of agents to increase cAMP versus 8-bromo-cAMP alone, and these groups were combined for analysis.
Reactions were terminated by snap freezing on a dry ice methanol bath and the cells were lysed by thawing in 1 ml of a buffer containing 1% NP-40, 100 mM sodium pyrophosphate, 250 mM NaCl, 50 mM NaF, 5 mM EGTA, 0.1 mM PMSF, 10 gg/ml leupeptin, 15 mM flmercaptoethanol, and 20 mM Tris-HCI (pH 7.9). The lysate was sediment at l00,000 g for 5 min at 4VC, and the supernatant was incubated with 20 Ml of rabbit anti-human platelet myosin antibody (2 mg/ml) at 4VC for 1 h. 50 Ml of a prewashed S. aureus cell suspension (Pansorbin) was then added to the suspension, which was incubated for an additional 30 min at 4VC (20) . The mixture was centrifuged (100,000 g for 1 min) and the pellet was washed with 0.5 ml of the lysing buffer and recentrifuged. The pellet was then washed with 0.5 ml of a 50:50 mixture of lysing buffer and PBS. The pellet was resuspended in 200 Ml of SDS sample buffer for SDS-PAGE or 35 Ml of urea-lysing buffer for two-dimensional electrophoresis.
Isoelectric focusing. The unphosphorylated and phosphorylated MLC20 isoforms were separated by two-dimensional electrophoresis as described by Ludowyke et al. ( 15) but with the following modifications. The sample was suspended in 35 Ml of a buffer containing 9.5 M urea (ultrapure urea; Boehringer Mannheim Corp., Indianapolis, IN), NP-40, 0.04% pharmalyte (pH 4.5-5.4), 0.04% pharmalyte (pH 4-6.5) and 0.1 M DTT. Tube gels were prepared using 1.5 mm i.d. x 180-mm glass tubes. For 10 tubes, 2.78 g of ultra pure urea was mixed with 1.5 ml of H20, 0.83 ml of 30%:0.8% acrylamide/bisacrylamide, 0.28 ml of pharmalyte (pH 4-6.5), 0.28 ml of pharmalyte (pH 4.5-5.4), and 0.28 ml ofCHAPS buffer (100 mg CHAPS, 0.3 ml H20, and 0.03 ml NP-40). Gels were drawn to a height of 150 mm. Gels were polymerized with 5 ul of TEMED and 10 Ml ammonium persulfate. Isoelectric focusing was performed using a cell (model 175; Bio-Rad Laboratories (Richmond, CA).
The anolyte contained 0.01 M glutamic acid and the catholyte contained 0.01 M histidine. Gels were prefocused at 25°C at 200 V for 2 h followed by 500 V for 5 h. 30-,Ml samples were loaded onto the gel, covered with 10 Ml of an overlaying buffer, which contained 8 M urea, 2% pharmalyte (pH 3-10), and 0.5% pharmalyte (pH 4.5-5.4). Catholyte buffer was layered over the overlaying buffer. The samples were then electrophoresed at 2,500 V for an additional 32,000 V h.
Second Dimension SDS-PAGE. Tube gels were extracted and rinsed with transfer solution (3% SDS, 0.07 M Tris-Base (pH 6.7), and 0.03 mg/ml bromphenol blue), layered onto a polyacrylamide/bisacrylamide slab gel ( 1 5%:0.4%), and sealed to the slab gel with hot agar (2.3% SDS, 0.062 M Tris-Base (pH 6.8), 0.5% agarose, and 5% 3-mercaptoethanol). The gels were run at 4°C for 18 to (21) . Peptide migration was monitored by the movement of acid fuschin dye toward the anode. Plates were then dried and subjected to ascending chromatography using 1-butanol/acetic acid/pyridine/water (49:8:38:30). Plates were then dried, wrapped in cellophane, and autoradiographs were developed using Kodak X-Omat AR film.
Phosphoamino acid analysis. Peptides that were generated from two-dimensional TLC maps were scraped from the TLC plate and eluted with 50 mM NH4HCO3. The peptide was then lyophilized, washed with water, and lyophilized again to remove the ammonium bicarbonate. Peptides were subjected to acid hydrolysis in 6 N HCO at 120'C for 3 h and then relyophilized. Dry residue was washed with water and relyophilized. Labeled phosphoamino acids were resuspended in electrophoresis buffer (acetic acid/formic acid/water, 9:3:88), which contained 2 ,g/,gl of phosphothreonine and phosphoserine, and were then spotted onto a TLC plate. Amino acids were subjected to electrophoresis at 700 V for 2 h and 50 min at 4VC. Labeled phosphoamino acids were detected by autoradiography and identified by comparing the corresponding migration ofthe phosphoamino acid standards, which were stained with ninhydrin.
Measurement ofintracellular cAMP. HUVECs plated on polycarbonated filters were exposed to control media (M199 without serum), histamine ( I0-' M), or cAMP mixture (forskolin [2 X I0-5 MJ and theophylline [ 10 -3 M ]). After the indicated time intervals, the medium was aspirated and the cells were extracted twice with 1 ml of ethanol. The extracts were combined and centrifuged at 3,000 g for 15 min at 4°C. The supernates were dried under nitrogen and reconstituted in the sample buffer provided (cAMP 3H Assay System; Amersham Corp., Arlington Heights, IL). The rest of the analysis system was conducted as described in the directions for the assay system.
In vitro phosphorylation assays. Standards for tryptic peptide maps of MLC20 were generated in vitro from turkey gizzard MLC20 or plate- The most basic of the 20-and 19.7-kD isoforms were unphosphorylated as they were not detectable in 32P-labeled cells (Fig.  1 B) . Similarly, the 16-kD isoforms were unphosphorylated as they were also not observed in 32P-labeled cells (Fig. 1 B) . Kawamoto et al. ( 14) also found 20-and 19.7-kD phosphorylated isoforms and a 1 6-kD isoform in platelets. Unlike human platelet and smooth muscle MLC, the unphosphorylated A and B isoforms of HUVECs are focused adjacent to each other ( 14, 22) . Also, the 16-kD isoform existed at only one isoelectric point in human platelets whereas in HUVECs there are two 1 6-kD isoforms with distinct isoelectric points (Fig. 1 A) .
The 20-and the 19.7-kD isoforms each focused at three distinct isoelectric points, corresponding to the unphosphorylated, monophosphorylated, and diphosphorylated states of each isoform. The unphosphorylated isoforms were focused toward the basic end where isoform B had a higher molecular mass and more acidic isoelectric point than isoform A. The corresponding mono-and diphosphorylated isoforms ofA and B were focused toward the acidic end and were arbitrarily designated A', B' and A", B", respectively (Fig. 1 A) . We confirmed the identity of the unphosphorylated isoforms in 35S-labeled cells by depleting cells ofATP using antimycin A and deoxyglucose (23) . ATP depletion generated two isoforms, which corre- sponded to the unphosphorylated isoforms A and B (data not shown). The identity of the mono-and diphosphorylated isoforms were confirmed by separation of the isoforms from cells labeled with 32p ( Fig. 1 B) .
Quantitating phosphorylation ofmyosin light chain The effect ofhistamine on MLC20 phosphorylation. Histamine phosphorylation. This was evident as a relative increase in the intensity of MLC20 that migrated as mono-and diphosphorylated isoforms (Fig. 2, A and B) . In unstimulated cells, the intensity of unphosphorylated MLC20 isoforms (A and B)
greatly exceeds the corresponding intensity of the monophosphorylated isoforms (A' and B'). In contrast, in HUVECs exposed to histamine, the intensity of the unphosphorylated MLC20 isoforms is almost equal to the intensity of the corresponding monophosphorylated isoforms. This indicates that increased MLC20 phosphorylation occurs when HUVECs are exposed to histamine. Expressed as stoichiometry, histamine induced a modest increase in the number of mol phosphate/mol MLC20 in HUVECs (Fig. 3) . 30 s after exposure to histamine MLC20 phosphorylation was 0.16±0.05 (isoform B) and 0.19±0.05 (isoform A) mol phosphate/mol light chain greater in histamineexposed cells than in control cells. This represented the peak increase in histamine-stimulated phosphorylation. The increased phosphorylation ofMLC20 persisted through 90 s when MLC20 phosphorylation in histamine-exposed cells was 0.16±0.04 (isoform B) and 0.17±0.04 (isoform A) mol phosphate/mol light chain greater than it was in control cells. However, by 5 min MLC20 phosphorylation in histamine-exposed cells was no longer different than it was in control cells, and it remained at the control level 15 min after histamine exposure. lonomycin produced a much greater increase in MLC20 phosphorylation than did histamine (Fig. 4) . 90 s after initiating exposure to 5 X 10-6 M ionomycin MLC20 phosphoryla- The effect ofincreasing intracellular cAMP on MLC20phos-phorylation. Increasing cAMP in HUVECs decreased MLC20 phosphorylation and prevented histamine from increasing phosphorylation above levels found in control cells. cAMP alone shifted the isoform distribution toward the unphosphorylated isoforms and, in histamine-exposed cells, cAMP pretreatment prevented the expected shift towards the mono-and diphosphorylated isoforms (Figs. 2, Cand D) . This shift in the isoform distribution represented a decrease in MLC20 phosphorylation of0.19±0.02 (isoform B) and 0.17±0.02 (isoform A) mol phosphate/mol light chain in cAMP-treated cells (Fig.  5) . Similarly, cells treated with cAMP and then histamine had 0.09±0.02 (isoform B) and 0.08±0.02 (isoform A) fewer mol phosphate/mol light chain than did control cells (Fig. 5) .
The effect ofhistamine on cellular cAMP. The rapid return of MLC In vitro standards were generated by phosphorylating turkey gizzard smooth muscle MLC or human platelet MLC with smooth muscle MLCK or rat brain PKC (each kinase displayed the same map whether smooth muscle or nonmuscle MLC was used). Fig. 6 shows the two-dimensional TLC peptide map oftryptic fragments from turkeygizzard MLC20 phosphorylated in vitro by MLCK and PKC. The map of the MLCK standard (Fig. 6 a) consisted of a single dominant phosphorylated peptide fragment (peptide A), which contained only phosphoserine. The migration ofthis fragment was consistent with that of a fragment previously identified as containing phosphorylated ser'9 (14) . The map of the PKC standard (Fig. 6 b) demonstrated three peptides. Peptide B, a minor peptide, contained only phosphoserine. Peptide C, a major peptide, also contained only phosphoserine. The migration of these fragments is consistent with that of fragments previously identified as containing monophosphorylated ser' or ser2 ( 14) .
Peptide D is a major peptide that contains only phosphothreonine, and its migration is consistent with previous reports ofa fragment containing monophosphorylated thr9 ( 14) .
Tryptic fragments of MLC20 phosphorylated in situ in HUVECs demonstrated a phosphorylated tryptic peptide (peptide 1, Fig. 7 A) similar to the one obtained with the MLCK standard. The peptide map of digest from control HUVECs also demonstrated another phosphorylated tryptic peptide (peptide 2, Fig. 7 A) . Peptide 1 migrated to a similar position as the monophosphorylated ser'9 in vitro standard. Peptide 2 was positioned near the origin, a migration pattern previously identified for a tryptic fragment diphosphorylated on thr'8 and ser'9 (24) . This pattern is unaltered even if repeated digestion is extended for 48 h. When digest from control cells was mixed with digest from the MLCK standard and separated by the same two-dimensional TLC procedures, peptide 1 comigrated with the monophosphorylated ser'9 standard (Fig. 7 B) , confirming that peptide 1 represented a monophosphorylated peptide phosphorylated in situ by MLCK. Maps of MLC20 tryptic fragments from HUVECs exposed to histamine demonstrated the same two peptides as control cells (Fig. 7 C) . When digests from control cells and histamine-stimulated cells were mixed, the maps showed comigration ofboth peptides, indicating that MLCK mediates both basal and histamine-stimulated phosphorylation (Fig. 7 D) . Monophosphorylated senor2 peptides were not observed under resting and histamine-stimulated conditions. This indicates that PKC does not mediate phosphorylation in HUVECs under basal and histamine-stimulated conditions. In addition, phorbol dibutyrate PDBU (_10-6 M)exposed cells did not generate significant sernr2 fragments (data not shown).
The peptide map pattern did not change in cells exposed to cAMP agonists (Fig. 7 E) . Two-dimensional TLC maps of digests ofcAMP-stimulated cells revealed a peptide (peptide 1) that comigrated with the monophosphorylated ser'9 standard (Fig. 7 F) . Since cAMP decreased phosphorylation, and the peptide map was unaltered, cAMP decreased phosphorylation by decreasing MLCK activity and/or increasing dephosphorylation of MLC20.
Phosphoamino acid analysis ofin situ phosphorylated peptides. When peptides from two-dimensional TLC maps of unstimulated cells are eluted from the silica TLC plates and subjected to phosphoamino acid analysis, peptide 1 contained phosphoserine and phosphothreonine (Fig. 8) . Electrophoresis - (-) this suggests that peptide 1 is a mixture of monophosphorylated peptides that contained monophosphorylated ser'9 and monophosphorylated thr'8 peptides. Peptide 2 contains phosphoserine and phosphothreonine. As noted above, peptide 2 has been previously demonstrated to be a diphosphorylated ser19 and thr '8 peptide (24) . This phosphoamino acid analysis pattern is similar in histamine-stimulated cells (data not shown). The presence of phosphothreonine in peptide 1 suggest that, unlike smooth muscle cells, monophosphorylation at thr'8 by MLCK significantly occurs in the HUVEC.
Discussion
The intent of these experiments was to further explain how inflammatory molecules such as histamine cause adjacent endothelial cells to retract from each other ( 1-8) and how cAMP agonists oppose this response (2, 25) . Although the actin cytoskeleton of permeabilized endothelial cells contract after the addition of 100 ,M calcium, ATP, MLCK, and calmodulin ( 10, 11, 13), very little contraction and MLC20 phosphorylation occurs at 1-5 ,uM free calcium in these permeabilized cell models ( 13 ) . The limited contraction of endothelial cell cytoskeletons at 1-5 1AM calcium is especially relevant, since cell calcium remains in the high nanomolar range in stimulated endothelial cells. Histamine increased calcium in HUVECs to -650 nM in our earlier report, and this is consistent with other reports on histamine stimulation of HUVECs and the response ofendothelial cell calcium to other inflammatory molecules such as bradykinin (2, 26, 27 ).
In the experiments described in this manuscript we found that doses ofhistamine that increased HUVEC monolayer per- meability to albumin by 50-100%, increased MLC20 phosphorylation by -0.2 mol phosphate/mol MLC20 (approximately a 90% increase from baseline). Unstimulated HUVECs demonstrated constitutive phosphorylation. Histamine caused a rapid but transient increase in MLC20 phosphorylation and achieved maximal levels by 30 s. Maximal levels persisted at 90 s but returned to basal levels by 5 min. Of note is that the maximal levels of MLC20 phosphorylation in histamine-stimulated HUVECs is consistent with observed maximal changes in cell calcium. We and others have observed that histamine-stimulated increases in calcium are maximal by 15-30 s in HUVECs (2, 28) . The close temporal relationship between change in cell calcium and MLC20 phosphorylation in HUVE suggest a calcium dependence for MLC20 phosphorylation. It does not seem likely that the modest increase in MLC20 phosphorylation we observed represents a methodological problem. Exposing the cells to 5 ,M ionomycin produced an appropriately greater increase in MLC20 phosphorylation (0.5 mol phosphate/mol MLC20), and one that is similar to that observed in smooth muscle cells exposed to 10 ,M ionomycin for the same time (0.6 mol phosphate/mol MLC20, 90 s) ( 16) . Similarly, the levels of phosphorylation achieved in stimulated smooth muscle cells at time points earlier than 30 s were preserved at 30 s, so it is not likely that we missed higher levels of phosphorylation at earlier time points ( 16) . The increase in cell calcium observed in HUVECs stimulated with histamine is also preserved at these times (26) .
Since the level ofMLC20 phosphorylation should reflect the amount of isometric tension exerted on the underlying extracellular matrix, one would predict that unstimulated HUVECs should exert resting isometric tension since they display consti- tutive MLC20 phosphorylation. In addition, the amount ofisometric tension would be expected to increase in proportion to the increase in phosphorylation that results from receptor activation of inositol phospholipid hydrolysis (29 microvascular endothelial cells display constitutive wrinkling of silicone rubber matrix and further wrinkle when cells are exposed to vasoactive mediators. Therefore, the change in MLC20 phosphorylation and isometric tension is consistent with the hypothesis that activation of signal transduction may mediate an acute increase in isometric tension through the cytoskeleton.
In our experiments peak phosphorylation of MLC20 was observed 30 s after adding histamine. Kolodney and Wysolmerski (30) observed an increase in tension exerted by HU-VEC monolayers 30 s after adding thrombin. These relationships are consistent with MLC20 phosphorylation contributing to the initiation ofincreased tension development in HUVECs. However, Kolodney and Wysolmerski (30) found that peak tension developed after 5 min and persisted for 2 40 min after adding thrombin. We found that MLC20 phosphorylation had returned to basal levels by 5 min and remained there at 15 min. Maintaining tension even after MLC20 phosphorylation approaches basal levels may be analogous to smooth muscle cells (29) . Other effects of activation of the signal transduction cascade, such as recruitment of the actin cytoskeleton, may also contribute to the persistent tension ( 17 ). Similar to what Fox and Phillips (33) found in platelets, Carson et al. (34) recently found that histamine increased the fraction of actin that was present as filamentous actin in HUVECs.
To explain the transient increase in MLC20 phosphorylation in HUVECs exposed to histamine, we asked whether MLC20 phosphorylation returns to baseline because cell cAMP levels increase. Hekimian et al. (35) recently demonstrated that histamine increased cell cAMP levels in bovine aortic endothelial cells through a H2 receptor. We did not observe any significant increase in cell cAMP from baseline in HUVECs exposed to histamine.
As noted above, histamine increases both calcium and diacylglycerol in HUVECs. Hence, histamine could activate calcium-calmodulin-dependent kinases (MLCK) or DAG-dependent kinases (PKC). Since PKC-mediated MLC phosphorylation has been associated with platelet and basophil activation, it was of interest to us to determine which kinase was responsible for phosphorylation of MLC20 in HUVECs, both at rest and after stimulation with histamine ( 14, 15) . We found that both basal and histamine-stimulated MLC20 phosphorylation in HUVECs were mediated by MLCK, and we found no evidence for MLC phosphorylation by PKC in HUVECs, even when the cells were stimulated with PDBU.
We previously found that increasing HUVEC cAMP decreased basal permeability and prevented histamine from increasing the permeability of HUVEC monolayers but did not prevent the increase in cell calcium (2) . In the current experiments we found that increasing HUVEC cAMP markedly reduced phosphorylation of MLC20 and prevented an increase with histamine. Hence, the effect ofcAMP on histamine stimulation of MLC20 phosphorylation correlates with our earlier report on in vitro permeability (2) . We also observed that MLCK mediates MLC20 phosphorylation under cAMP-stimulated conditions. Our data suggest that A kinase modulates MLC20 phosphorylation indirectly by either decreasing the basal activity of MLCK or enhancing phosphatase activity ( 17, 36). Conti and Adelstein (37) has shown that A kinase can phosphorylate and decrease MLCK activity. Phosphorylated MLCK binds poorly to the calcium-calmodulin complex, and contraction is prevented even when signal transduction is activated. On the basis of our results, it is conceivable that modulation of MLCK activity may be an important regulatory step in the control of endothelial barrier function.
In reports from others and ourselves, cAMP reduces the basal permeability of monolayers of endothelial cells (2, 25, 38) . Whether a decrease in the level ofMLC20 phosphorylation enhances endothelial barrier function is unclear. Using silicon rubber matrix, other investigators have shown that increasing cell cAMP induces matrix relaxation (31, 32) . If centripetal isometric tension opposes tethering forces that link cells and substrate together, then, perhaps, a decrease in MLC20 phosphorylation could decrease opposing tension on tethering forces which, in turn, could enhance adhesive forces between adjacent cells and cells to substrate. This could enhance barrier function. However, other effects of A kinase activation independent of MLC phosphorylation could also contribute to the enhanced barrier function, and it is not yet certain if cAMP prevents the response to histamine only by reducing MLC20 phosphorylation or whether there are also other effects of cAMP that may prevent the increase in permeability (2) .
Earlier reports of MLCK-mediated phosphorylation of MLC20 had identified ser 9 as the preferred site of MLCK phosphorylation both in situ and in vitro in smooth muscle (24, 39, 40) . The thr'8 site has been shown to be diphosphorylated only under extreme in vitro conditions (39) . However, phosphoamino acid analysis of the monophosphorylated peptide from HUVECs demonstrated phosphothreonine, suggesting that thr'8 may be an acceptable monophosphorylation site in HUVECs. It is unclear what effect monophosphorylation at thr'8 would have on the actin-stimulated myosin ATPase activity compared with monophosphorylation at ser'9. Diphosphorylation at thr'8 has been shown to augment and to have no effect on actomyosin contraction (24, (40) (41) (42) . Protein sequencing of the threonine phosphorylated fragment will be necessary to confirm the identity ofthe monophosphorylated thr 8 peptide.
The isoelectric focusing patterns of the MLC20 isoforms from HUVECs were similar to, but not the same as, those reported in human platelets and smooth muscle ( 14, 22) . HUVECs demonstrated two 1 6-kD isoforms whereas in platelets there was only one 16-kD isoform. Also the isoform pattern of the 20-kD isoforms is unique. Other work has suggested that MLCs of nonmuscle cells may be encoded by different genes than those in smooth muscle cells (43) . Our own observations would suggest that there are subtle differences among the isoforms in smooth muscle, platelets, and endothelial cells, and these differences could contribute to differences in functional response.
In summary, doses ofhistamine that increase the permeability of monolayers of HUVECs caused a modest increase in MLC20 phosphorylation in HUVECs, and the phosphorylation was mediated by MLCK. The amount ofhistamine-stimulated phosphorylation was consistent with the increase in HUVEC calcium that occurs with histamine stimulation, and further increases in cell calcium with ionomycin caused an appropriately greater increase in MLC20 phosphorylation. Increases in cell cAMP reduced basal phosphorylation of MLC20 and prevented the histamine-stimulated increase in MLC20 phosphorylation. Although these data are consistent with the hypothesis that MLC20 phosphorylation contributes to retraction of HUVECs stimulated with histamine, it does not rule out other mechanisms that may regulate cell retraction during inflammation independent of actomyosin contraction.
